Literature DB >> 12597941

Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source.

R Waidelich1, W Beyer, R Knüchel, H Stepp, R Baumgartner, J Schröder, A Hofstetter, M Kriegmair.   

Abstract

OBJECTIVES: To determine whether whole bladder photodynamic therapy after intravesical administration of 5-aminolevulinic acid using a white light source would destroy urothelial carcinoma. We sought to define the optimal target group of patients for this therapy. The side effects of treatment were also assessed.
METHODS: We performed whole bladder photodynamic therapy with 100 J/cm(2) white light 2 to 4.5 hours after intravesical administration of 17% 5-aminolevulinic acid in 12 patients with recurring, multifocal, Stage pTa, grade I to III, urothelial tumors of the bladder and carcinoma in situ.
RESULTS: Immediately after whole bladder irradiation, histologic examination of biopsies taken from flat suspicious lesions showed no viable cells; remnants of malignant cells were found in papillary tumors. Of the 12 patients, 11 returned for follow-up examination. At a median follow-up of 18 months (range 3 to 25), 3 of the 7 patients with carcinoma in situ and 2 of the 4 patients with papillary tumors were free of disease. In all patients, urinary frequency and urgency subsided within 3 weeks. No decreased bladder capacity or systemic side effects were observed.
CONCLUSIONS: Our preliminary data show that whole bladder photodynamic therapy with intravesically applied 5-aminolevulinic acid using a white light source is effective in destroying flat malignant lesions of the bladder such as carcinoma in situ. The procedure is easy to perform and is not associated with any major side effects. The findings warrant long-term and multicenter studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12597941     DOI: 10.1016/s0090-4295(02)02164-7

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  16 in total

Review 1.  A review of progress in clinical photodynamic therapy.

Authors:  Z Huang
Journal:  Technol Cancer Res Treat       Date:  2005-06

Review 2.  The future of lasers in urology.

Authors:  Sean A Pierre; David M Albala
Journal:  World J Urol       Date:  2007-06-14       Impact factor: 4.226

Review 3.  Photodynamic therapy: occupational hazards and preventative recommendations for clinical administration by healthcare providers.

Authors:  John D Breskey; Steven E Lacey; Benjamin J Vesper; William A Paradise; James A Radosevich; Michael D Colvard
Journal:  Photomed Laser Surg       Date:  2013-07-16       Impact factor: 2.796

Review 4.  Photodynamic therapy of cancer: an update.

Authors:  Patrizia Agostinis; Kristian Berg; Keith A Cengel; Thomas H Foster; Albert W Girotti; Sandra O Gollnick; Stephen M Hahn; Michael R Hamblin; Asta Juzeniene; David Kessel; Mladen Korbelik; Johan Moan; Pawel Mroz; Dominika Nowis; Jacques Piette; Brian C Wilson; Jakub Golab
Journal:  CA Cancer J Clin       Date:  2011-05-26       Impact factor: 508.702

Review 5.  A Surgical View of Photodynamic Therapy in Oncology: A Review.

Authors:  K Moghissi; Kate Dixon; Sally Gibbins
Journal:  Surg J (N Y)       Date:  2015-10-15

6.  Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response.

Authors:  Ramaswamy Bhuvaneswari; Yik Yuen Gan; Khee Chee Soo; Malini Olivo
Journal:  Mol Cancer       Date:  2009-11-02       Impact factor: 27.401

7.  The effect of 5-aminolevulinic acid and its derivatives on protoporphyrin IX accumulation and apoptotic cell death in castrate-resistant prostate cancer cells.

Authors:  Ervin Teper; Peter Makhov; Konstantin Golovine; Daniel J Canter; Cynthia B Myers; Alexander Kutikov; Steven N Sterious; Robert G Uzzo; Vladimir M Kolenko
Journal:  Urology       Date:  2012-08-28       Impact factor: 2.649

8.  Chlorin-based photodynamic therapy enhances the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in bladder cancer cells.

Authors:  Ewelina Szliszka; Zenon P Czuba; Aleksandra Kawczyk-Krupka; Karolina Sieron-Stoltny; Aleksander Sieron; Wojciech Krol
Journal:  Med Sci Monit       Date:  2012-01

Review 9.  Dual roles of nitric oxide in the regulation of tumor cell response and resistance to photodynamic therapy.

Authors:  Valentina Rapozzi; Emilia Della Pietra; Benjamin Bonavida
Journal:  Redox Biol       Date:  2015-07-31       Impact factor: 11.799

Review 10.  Treatment options in non-muscle-invasive bladder cancer after BCG failure.

Authors:  Nathan A Brooks; Michael A O'Donnell
Journal:  Indian J Urol       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.